Want to join the conversation?
$AMGN's other revenues increased $24MM in 3Q15 due primarily to a milestone received for the filing of Kyprolis in Japan. $AMGN expects to increase quarterly dividend to $1 per share in 1Q16, up 27% and expects to face increased competition for its legacy products. For 4Q15, OpEx is expected to increase by around $0.2Bil sequentially.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?